300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Blockchain
Facebook
Social Network
B2B
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Nigeria
Isle of Man
Pakistan
Zambia
Romania
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Colombia
Oman
Cameroon
Australia
India
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Cayman Islands
Kenya
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Germany
Seychelles
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United Kingdom
United States
Canada
Ireland
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 30 Biotechnology Angel Investors in LATAM (June 2026)

The most active angel investors investing in LATAM Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in LATAM Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Kevin Efrusy
Angel
2 Brazil, United States, Mexico Series B, Series A, Series C Software, E-Commerce, FinTech $6M–$100M
Ashton Kutcher
Angel
1 United States, Germany, Canada Seed, Series A, Series B Software, E-Commerce, Apps
Martin Torres Cava
Angel
1 Peru Pre-Seed Medical, Wellness, Health Care
Daniel Gold
Angel
1 Brazil Pre-Seed Genetics, Life Science, Biotechnology
Ignacio Smith
Angel
1 Chile Seed Farming, Chemical, Agriculture
Guilherme Leal
Angel
1 Brazil Series A Chemical, Biopharma, Biotechnology
Jason Burke
Angel
1 United States, Mexico Seed, Pre-Seed, Angel Health Care, Information Technology, Internet
Eric Urhane
Angel
1 United States, Mexico, Singapore Seed, Angel Software, Health Care, Biotechnology $1.1M–$1.9M
Peter Andersen
Angel
1 Brazil Series A Chemical, Biopharma, Biotechnology
Matt Cutts
Angel
1 United States, Canada, Mexico Seed, Angel, Series A SaaS, Health Care, Medical $493k–$2.8M
Allen Miner
Angel
1 Japan, United States, Canada Seed, Series B Software, SaaS, Retail $429k–$20M
Thomas James
Angel
1 Mexico Seed Health Care, Biotechnology, Health Diagnostics $52k–$1.9M
Robert Stavis
Angel
1 United States, Canada, Mexico Series C, Series B, Series A Financial Services, FinTech, Finance $3.9M–$126M
Paul Buchheit
Angel
1 United States, Canada, India Seed, Series A, Angel Software, E-Commerce, Health Care $100k–$13M
Pablo Pla
Angel
1 Argentina Seed Biopharma, Biotechnology, Food Processing
Fabricio Bloisi
Angel
1 Brazil, Colombia, Argentina Series A, Seed Software, Mobile, Internet $4M–$10M
Armínio Fraga
Angel
1 Brazil Seed, Pre-Seed, Series A Recruiting, SaaS, EdTech
Mark Gormley
Angel
1 United States, Mexico Series A, Private Equity, Secondary Market Insurance, Service Industry, AgTech
Dan Knox
Angel
1 Mexico, United States Seed Finance, Health Care, Crowdfunding
Tim Draper
Angel
1 United States, United Kingdom, Canada Seed, Series A, Series B Software, FinTech, Financial Services $400k–$50M
Francisco Miranda
Angel
1 Chile Seed Biotechnology, Food Processing, Meat and Poultry
Elizabeth Iorns
Angel
1 United States, Canada, Mexico Seed, Pre-Seed Software, SaaS, Health Care $1.9M–$3M
Jeff Horing
Angel
1 United States, Israel, Canada Series B, Series A, Series C Software, Artificial Intelligence, Information Technology $8.7M–$210M
Sohail Prasad
Angel
1 United States, France, Mexico Seed, Series A Software, Human Resources, Financial Services $1.1M–$25M
Jun Ueki
Angel
1 Argentina Seed Biopharma, Biotechnology, Food Processing
Eduardo Mufarej
Angel
1 Brazil, Colombia, United States Seed, Pre-Seed, Series C EdTech, Biotechnology, Fuel $1M–$2M
Mat Travizano
Angel
1 Spain, Argentina Seed, Series A PaaS, Bitcoin, FinTech $3.6M–$6.4M
Geoffrey KALISH
Angel
1 Mexico Series A AgTech, Seafood, Biotechnology
Bob Goodman
Angel
1 United States, Mexico, Germany Series B, Series C, Series A Software, SaaS, Enterprise Software $3.9M–$100M
Steve Zurcher
Angel
1 Argentina Seed Biopharma, Biotechnology, Food Processing
Access all 30 angel investors in LATAM Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Kevin Efrusy
Angel · Palo Alto, California, United States · 2 investments in LATAM Biotechnology startups

Kevin Efrusy is the Co-Founder of The Efrusy Family Foundation and a Partner at Accel. Prior to that, he was the CEO and board member, and co-founder of IronPlanet. He attended Stanford University Graduate School of Business and Stanford University.

Show more...

Investment focus

  • Industry: Software, E-Commerce, FinTech
  • Stage:Series B, Series A, Series C
  • Geography: Brazil, United States, Mexico

Investor stats

  • Total investments: 72
  • Round size: Series A $6M–$30M; Series B $10M–$35M; Series C $11M–$100M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Zubale — Zubale is the critical infrastructure that enables retailers to win in e-commerce. Through our gig workers marketplace and technical integrations we power our clients entire back end e-commerce operations delivering the best fill-rates, on-times and NPS. In the last year, Zubale has completed over 3 million jobs across 90 cities and 16,800 stores.We operate in Mexico, Colombia and Costa Rica and are scaling across Latin America. The Co-Founders Allison Campbell and Sebastian Monroy met during their Harvard MBA and are retail insiders with deep expertise at Walmart and P&G in Latin America, Africa, India and China.
  • Lemon Energy — A Lemon leva energia solar para a sua empresa, sem obras e com economia anual na conta de luz.
  • PhageLab — Record time development of tailor-made solutions to control bacterial outbreaks in the livestock and poultry industries.
Show all investments...

Ashton Kutcher
Angel · Los Angeles, California, United States · 1 investments in LATAM Biotechnology startups

Ashton Kutcher is an actor, investor, entrepreneur, producer and philanthropist.Kutcher has been named one of TIME magazine’s “100 Most Influential People in the World,” as well as being honored by Vanity Fair ‘s “New Establishment List,” which identifies the top 50 of an innovative new breed of buccaneering visionaries, engineering prodigiesand entrepreneurs. Twice, Kutcher was named one of Forbes magazine’s “World’s Most Powerful Celebrities,” as well as one of Fast Company magazine’s “Most Creative People.”Kutcher has been investing in technology for over a decade, both as an angel investor and a founding partner of A-Grade Investments and Sound Ventures. His fund portfolio includes Airbnb, Uber, Flexport, Brex, Robinhood, Bird, Airtable and Affirm among others.Kutcher is also the co-founder of Thorn: Digital Defenders of Children (www.thorn.org). Thorn drives technology innovation to fight the sexual exploitation of children.Kutcher currently stars in the Netflix original series, The Ranch. He also serves as Executive Producer. Until 2015, Kutcher starred in the CBS comedy series Two and a Half Men. The show ranked as the second most-watched comedy on all of network television. Kutcher first gained recognition as Michael Kelso on the Fox series That 70’s Show, and went on to star in a variety of box office hits on the big screen – including What Happens In Vegas with Cameron Diaz, The Guardian with Kevin Costner, No Strings Attached with Natalie Portman and the cult hit Dude, Where’s My Car.Kutcher served as co-creator and producer of MTV's hit series, “Punk'd,” and The CW's reality series “Beauty and the Geek” and “True Beauty.” He has also produced films such as No Strings Attached, Killers and The Butterfly Effect. Additionally, Kutcher co-founded APlus, a digital media company devoted to spreading the message of positive journalism, a kind of storytelling that focuses on our shared humanity. In 2016, APlus was purchased by Chicken Soup for the Soul.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Apps
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 111
  • Lead/follow: no public data

Portfolio highlights

  • QD-SOL — QD-SOL uses nanoparticles to produce green hydrogen in half the time.
  • Spicewell — Spicewell develops and creates food seasoning products that includes various kinds of micronutrients. It uses modern science to infuse healthy and organic additions to food meals. Spicewell is based in California, USA.
  • HempNFibers — Growing hemp. Making a bio fuel to start. Than also an insulation out of it as well. Will look at doing more as company grows. I also know a way to power a whole warehouse by just the plants it’s self but I need funding to get this started. I’m building the transportation side just so I can gain an income to try and get this started.
Show all investments...

Martin Torres Cava
Angel · Lima, Lima, Peru · 1 investments in LATAM Biotechnology startups

Doctor specialized in Diagnostic Imaging with more than 25 years of experience, also specialized in Breast Radiology, Occupational Health and Health Management, as well as in technological developments

Show more...

Investment focus

  • Industry: Medical, Wellness, Health Care
  • Stage:Pre-Seed
  • Geography: Peru

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Veo365 — Veo365 is a mobile/desktop solution for medical monitoring, occupational health, epidemiological surveillance, health education/prevention and real-time operational standards for companies, organizations, and in general for communities and governments. Their digital solution also integrates wearables and machine learning for a betterhealth diagnostic experience.Veo365 is headquartered in Lima, Peru and was founded in 2019.
Show all investments...

Daniel Gold
Angel · 1 investments in LATAM Biotechnology startups

Daniel Gold

Show more...

Investment focus

  • Industry: Genetics, Life Science, Biotechnology
  • Stage:Pre-Seed
  • Geography: Brazil

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • gen-t — Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.
Show all investments...

Ignacio Smith
Angel · 1 investments in LATAM Biotechnology startups

Ignacio Smith

Show more...

Investment focus

  • Industry: Farming, Chemical, Agriculture
  • Stage:Seed
  • Geography: Chile

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Botanical Solutions — BSI produces plant-based biofungicides for sustainable agriculture & advanced botanical materials for the gold standard vaccine adjuvant QS-21
Show all investments...

Guilherme Leal
Angel · 1 investments in LATAM Biotechnology startups

Guilherme Leal is the founder of Arapyaú.

Show more...

Investment focus

  • Industry: Chemical, Biopharma, Biotechnology
  • Stage:Series A
  • Geography: Brazil

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nintx — Next Innovative Therapeutics involves advancing therapies to the end of preclinical studies, and Nintx develops therapies targeting biological pathways directly and indirectly through gut microbiome modulation.
Show all investments...

Jason Burke
Angel · Boston, Massachusetts, United States · 1 investments in LATAM Biotechnology startups

Jason Burke is the Co-founder, Managing Director, and Investor of TBD Angels and the VP of Strategy and Business Development of Xandr. Prior to that, he was the Chief Strategy Officer for clypd, a Boston-based startup building an advertising technology platform exclusively for the TV industry and designed to empower media companies with actionablesales tools. In his role, Burke focuses on a forward-looking platform and business strategy, corporate development, partnerships, and management of clypd's strategic commercial deals.As one of the first employees at clypd, Burke spent over 3 years as VP, Product leading the product & operations teams in bringing innovative products to the $180B television advertising market. Prior to clypd, Burke spent six years building ad technology products for online video at ScanScout and Tremor Video where he had responsibility for product management, technical strategy and operations efforts.Jason is a leader with the unique experience of working with executive customer teams and internal product development/engineering groups to drive business while also solving software and implementation challenges with internal and external technical teams. He is also a frequent contributor to industry publications and participant on advertising technology and media conference presentations and panels. Jason holds several software patents focused on inventions in advertising technology and media.Jason is also an investor in early-stage companies across several verticals. He feels privileged to invest in and collaborate with talented founding teams seeking to change the world with innovative products & businesses.Jason is based in Boston and has degrees in Computer Science and Engineering Psychology from Tufts University.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Internet
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, Mexico

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Eva — Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks. The company's wearable device is equipped with tactile sensors which are designed to map the surface of the breast and surrounding areas, allowing women to keep a track on the changes in breast temperature, size, and weight, with the help ofbiosensors inside the cup which constantly monitors information.
  • Wrangle — Wrangle organizes requests in your Slack team channel. Automatically assign approvals and tasks for your team to follow up and track their status.
  • WorkAround — WorkAround is the accurate, scalable solution for adding human input to your data using an untapped workforce of domain experts.WorkAround's platform enables simple, quick annotation of data. Anything from classifying expenses into tax codes, annotating breast tissue to identify regions of interest, to identifying drug combinations fromclinical trial reports. We have the domain experts and a platform to facilitate a simple, secure processing of customer data and annotations.Companies that using WorkAround services not only save time and get quality service, but are also contributing to a more socially just and productive world where talent knows no boundaries, opportunity doesn’t ask for status, and work is rewarded with fair pay.
Show all investments...

Eric Urhane
Angel · 1 investments in LATAM Biotechnology startups

Eric Urhane

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Angel
  • Geography: United States, Mexico, Singapore

Investor stats

  • Total investments: 5
  • Round size: Seed $1.1M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Show all investments...

Peter Andersen
Angel · Walnut Creek, California, United States · 1 investments in LATAM Biotechnology startups

Peter Andersen

Show more...

Investment focus

  • Industry: Chemical, Biopharma, Biotechnology
  • Stage:Series A
  • Geography: Brazil

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nintx — Next Innovative Therapeutics involves advancing therapies to the end of preclinical studies, and Nintx develops therapies targeting biological pathways directly and indirectly through gut microbiome modulation.
Show all investments...

Matt Cutts
Angel · San Francisco, California, United States · 1 investments in LATAM Biotechnology startups

Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his

Show more...

Investment focus

  • Industry: SaaS, Health Care, Medical
  • Stage:Seed, Angel, Series A
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 11
  • Round size: Seed $493k–$2.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Meter Feeder — Easily pay for parking through MeterFeeder
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Allen Miner
Angel · Tokyo, Tokyo, Japan · 1 investments in LATAM Biotechnology startups

Allen Miner is a founder/General Partner of SunBridge Partners and the founder/CEO of SunBridge Corporation. Allen has significant experience in Internet, enterprise and open-source software, entrepreneurship, and international technology transfer. Allen has been actively involved in each of the firm’s investments resulting in numeroussuccessful IPOs, including salesforce.com, MacroMill, ITMedia and G-Mode, among others. Allen is currently a member of the Board of Directors of salesforce Japan.Allen graduated from Brigham Young University with degrees in Computer Science and Asian Studies. He joined Oracle Corporation in 1986 and was dispatched to Japan, where he founded and helped lead Oracle Japan to a successful IPO on the Japan stock market. Allen returned from Japan in 1996 to serve as Oracle’s Vice President in charge of Linux/Open Source.Allen created SunBridge Corporation in 1999. Allen currently serves on the Boards of several SunBridge portfolio companies and as an advisor to government-affiliated organizations focused on innovation and entrepreneurship. He was appointed to the Board of Directors of the Japan Venture Capital Association upon its founding in 2002.

Show more...

Investment focus

  • Industry: Software, SaaS, Retail
  • Stage:Seed, Series B
  • Geography: Japan, United States, Canada

Investor stats

  • Total investments: 36
  • Round size: Seed $600k–$16M; Series B $429k–$20M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
  • Favy — Favy is a platform that enables businesses such as restaurants and beauty salons to launch subscription services.
  • BONAVENTURA — BONAVENTURA is a luxury leather goods brand redefining the essence of next-generation luxury under the vision of 'Beyond Luxury,' combining a robust e-commerce foundation with an expanding network of retail stores.Embark on life's journey with BONAVENTURA, where Italian craftsmanship meets timeless design. Blending elegance,functionality, and premium materials, our creations are crafted to bring lasting joy and stand the test of time.The name "BONAVENTURA" and our symbol "Infinity Clover' symbolize good luck and eternal happiness for those who cherish life’s moments.
Show all investments...

Thomas James
Angel · 1 investments in LATAM Biotechnology startups

Thomas James

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Mexico

Investor stats

  • Total investments: 2
  • Round size: Seed $52k–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Miproto
Show all investments...

Robert Stavis
Angel · New York, New York, United States · 1 investments in LATAM Biotechnology startups

Robert Michael Stavis is based out of Larchmont, New York and is the Partner of Bessemer Venture Partners. Robert previously worked at NewSchools Venture Fund as a Director. Robert Stavis attended the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Finance
  • Stage:Series C, Series B, Series A
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 35
  • Round size: Series A $3.9M–$38M; Series B $9.3M–$126M; Series C $10M–$32M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • LNTS — LNTS has recognized the deficiencies in healthcare and through our proprietary technology and solution, we are making rehabilitation and performance far more efficient for patients, clinicians and providers. LNTSConnect.com
  • Flower Company — We sell weed on the internet. Thousands of products delivered overnight throughout California from Humboldt to San Diego
  • Bespoke Financial — Bespoke Financial is a licensed lender supporting cannabis companies. They alleviate working capital constraints across the entire cannabis supply chain. Bespoke supports their clients as they scale and grow with unique financing solutions and cannabis business loans.
Show all investments...

Paul Buchheit
Angel · Mountain View, California, United States · 1 investments in LATAM Biotechnology startups

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 152
  • Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$13M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
  • BuildForever — BuildForever build products that feel personal, magical and deeply human.
  • Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Pablo Pla
Angel · 1 investments in LATAM Biotechnology startups

Pablo Pla is the Chief Executive Officer of San Miguel. He Previously worked at Ingredion Incorporated as a President and General Manager. Pablo Pla attended Columbia Business School.

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology, Food Processing
  • Stage:Seed
  • Geography: Argentina

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
Show all investments...

Fabricio Bloisi
Angel · 1 investments in LATAM Biotechnology startups

Fabricio Bloisi is the CEO of Prosus Group. He previously worked at iFood as a CEO. Fabricio Bloisi attended Harvard Business School.

Show more...

Investment focus

  • Industry: Software, Mobile, Internet
  • Stage:Series A, Seed
  • Geography: Brazil, Colombia, Argentina

Investor stats

  • Total investments: 13
  • Round size: Series A $4M–$10M
  • Lead/follow: 92% lead, 8% follow

Portfolio highlights

  • Moova — Moova is a technological platform that captures idle last mile logistic capacity and transforms it into high efficiency and low cost shipping solutions. The platform connects E-Commerce and retail businesses with a fleet of "Moovers" who complete deliveries on their bicycle, motorcycle, car or van to generate an additional source ofincome. Through route optimization software, real-time traceability, flexible warehousing, and analytics, Moova is propelling the nascent E-Commerce industry in Latin America by reimagining the last mile for a sustainable world.
  • BioLinker — BioLinker is a production of synthetic biology, protein synthesis kits, and protein.
  • Mercadoni — Mercadoni operates an online shopping platform that allows customers to purchase from stores and supermarkets from their homes. It sells groceries, alcoholic beverages, and more. Antonio Nunes, Pedro Freire, Margarita Freitas, Francesco Lanzi and Nicolas Fernández Talice founded Mercadoni in 2015. It has its headquarters in Bogota in Colombia.
Show all investments...

Armínio Fraga
Angel · 1 investments in LATAM Biotechnology startups

Armínio Fraga

Show more...

Investment focus

  • Industry: Recruiting, SaaS, EdTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Brazil

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • gen-t — Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.
  • Jobecam — Jobecam is a SaaS which uses video technology to help recruiters to reduce unconcious biases during hiring process applying AI, concealing the candidates' identity, by blurring their images and changing their voices in the video interviews or video resume. With this, we help the decision-maker to evaluate candidates just for their competences,abilities and experiences instead of their gender, race, ethinic, religion, etc.Our IA do a match between the recruiter's requirements and the audio transcriptions from the video interviews to ranking the best profiles. In this point we already are by designed to reduce biases besides optimizing the hiring process, reducing unnecessary interviews.We are supported by Oracle, Estação Hack Facebook, Artemísia, IBMEC, People Strategy, BR and Harvard Angels BrazilThinking at efficiency and diversity during hiring process we are promoting a world to value difference in companies!Learn more at www.jobecam.com
  • Galena — Established in 2020, Galena trains and develops young talented individuals for the jobs of the future.
Show all investments...

Mark Gormley
Angel · New York, New York, United States · 1 investments in LATAM Biotechnology startups

Mark K. Gormley is a Partner at Lee Equity Partners. Prior to joining Lee Equity in 2006, Mr. Gormley was a Partner at Capital Z Financial Services Partners (“CZFS”), a leading financial services private equity firm, where he played a leading role in the operations and investment activities of the $1.85 billion fund. Mr. Gormley co-founded CZFS in1998 and shared responsibility for the oversight of all of the firm's investment and monitoring activities. Prior to founding CZFS, Mr. Gormley served as a Managing Director at Donaldson, Lufkin & Jenrette (“DLJ”), specializing in the insurance and asset management industries. While at DLJ, Mr. Gormley worked on corporate finance and merger and acquisition assignments, as well as on principal related activities on behalf of DLJ Merchant Banking. Prior to joining DLJ in 1989, he was a founding member of the Insurance Group at Merrill Lynch in 1985. Mr. Gormley serves or has served as a director of numerous public and private companies, including The Edelman Financial Group, Skopos Financial Group, Captive Resources, Carlile Bancshares, PDR Network, MidCap Financial, Universal American, Permanent General, NewStar Financial, British Marine Holdings, Catlin Group, Bank Handlowy, Ceska Sporitelna, NACOLAH among others. Mr. Gormley received a B.S.B.A. cum laude in Finance and Economics from the University of Denver and an M.B.A. from New York University.

Show more...

Investment focus

  • Industry: Insurance, Service Industry, AgTech
  • Stage:Series A, Private Equity, Secondary Market
  • Geography: United States, Mexico

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • McLarens — McLarens is an insurance industry leader providing claims management, loss adjusting and risk mitigation services to clients around the world.
  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
  • Simplicity Group — Simplicity is the leading partner for advisors, financial institutions, and consumers by delivering the best combination of wealth accumulation and financial protection products that meet the needs of a consumer-oriented holistic financial plan.
Show all investments...

Dan Knox
Angel · San Francisco, California, United States · 1 investments in LATAM Biotechnology startups

Dan Knox is one of the founders of Science Exchange, an online marketplace for science experiments. Prior to founding Science Exchange, Dan was Head of Operations at DailyMe, a pioneer in the field of dynamic personalization and predictive content and commerce presentation. Before joining DailyMe, Dan was Head of Economic Analysis within in theStrategy team at a leading commercial television network in the U.K., and a Senior Economist in the Media & Communications group of a global expert services consulting firm.Dan was part of the inaugural Executive MBA class at MIT Sloan School of Management. He also has a Master's degree and a Bachelor's degree in Economics, a Law degree and the Chartered Financial Analyst (CFA) qualification.

Show more...

Investment focus

  • Industry: Finance, Health Care, Crowdfunding
  • Stage:Seed
  • Geography: Mexico, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Experiment — Experiment is an online community and a crowdfunding platform for scientific research. It provides crowdfunding services for scientific research related to categories such as biology, chemistry, computer science, medicine, anthropology, psychology, engineering, and more.The platform provides its services for researchers from over 150institutions and universities around the world. It is in strategic partnerships with Experiment was founded by
Show all investments...

Tim Draper
Angel · San Francisco, California, United States · 1 investments in LATAM Biotechnology startups

Tim Draper is the Founding Partner of Draper Associates. He attended Harvard Business School.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 283
  • Round size: Seed $400k–$5.9M; Series A $2.5M–$25M; Series B $3M–$50M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • GALY — GALY biocrafts premium cocoa and cotton with quality, traceability, and scalable supply for modern brands.
  • Buupass — BuuPass is Kenya's market leader for online bus booking. We enable travelers to reserve seats and make payments in a convenient and timely way. Try BuuPass today!
  • Vivoo — Get personalized wellness insights with Vivoo's innovative, science-backed products. Understand your body's needs and take control of your body. Shop now!
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Francisco Miranda
Angel · Santiago, Region Metropolitana, Chile · 1 investments in LATAM Biotechnology startups

CEO of San Pablo Alimentos

Show more...

Investment focus

  • Industry: Biotechnology, Food Processing, Meat and Poultry
  • Stage:Seed
  • Geography: Chile

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • BeeTechnology — Biotech StartUp developing active ingredients for food to extend shelf-life, increase food quality and safety, with an organic approach
Show all investments...

Elizabeth Iorns
Angel · Palo Alto, California, United States · 1 investments in LATAM Biotechnology startups

Elizabeth Iorns is the Co-Founder, President, and CEO of Science Exchange. She previously worked at Y Combinator as a Part-time partner. Elizabeth Iorns attended the University of Auckland.

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 6
  • Round size: Seed $1.9M–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Torch — Transform your organization with Torch's leadership development solutions and drive lasting sustainable change.
  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Enzyme — Enzyme QMS software includes modules for all stages of the product development life cycle from Design Control to CAPA. Our in-house experts are here to back you up! We can guide you through the quality challenges and regulatory submission process. Sign up for a Demo today.
Show all investments...

Jeff Horing
Angel · New York, New York, United States · 1 investments in LATAM Biotechnology startups

Jeff Horing is based out of New York, New York and is the Managing Director of Insight Partners. Jeff previously worked at E.M. Warburg, Pincus & Co as a Team Member. Jeff Horing attended the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 73
  • Round size: Series A $8.7M–$125M; Series B $23M–$115M; Series C $42M–$210M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • FloVision Solutions — Food Analytics to maximize profits and minimize waste. FloWaste allows food service providers to optimize meal preparation, ingredient combinations, and portion sizing
  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
  • ScaleOps — ScaleOps is the industry's first Kubernetes optimization platform that automatically optimizes compute resources in real-time.
Show all investments...

Sohail Prasad
Angel · San Francisco, California, United States · 1 investments in LATAM Biotechnology startups

Sohail is the Founder & CEO of Destiny (D/XYZ).Sohail is also Founder & former Co-CEO of Forge, the stock market for private companies. He has an extensive background in product management, engineering, and business. As an eighteen-year-old, he was among the youngest founders to go through Y Combinator. Over the years, Sohail hasadvised and invested in over 100 startups, including notable startups such as Zenefits and Rappi. He continues to invest actively through S2 Capital, and serves as its Founding Partner. Prior to founding Equidate, Sohail managed mobile product at Zynga. He previously joined mobile advertising firm Chartboost as its second engineering hire, and has held roles at Google and the MIT Media Lab. Sohail was awarded TCU's Texas Youth Entrepreneur of the Year award in 2010, and was later named a Thiel Fellow by the Thiel Foundation. He previously attended Carnegie Mellon University where he studied Electrical & Computer Engineering.

Show more...

Investment focus

  • Industry: Software, Human Resources, Financial Services
  • Stage:Seed, Series A
  • Geography: United States, France, Mexico

Investor stats

  • Total investments: 12
  • Round size: Seed $1.1M–$7M; Series A $11M–$25M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Wethenew — Acquistate le vostre autentiche sneakers prodotti streetwear in edizione limitata in modo sicuro e protetto su wethenew.com!
  • Series — Series provides full-stack enterprise financial services designed for institutions & enterprises.
Show all investments...

Jun Ueki
Angel · 1 investments in LATAM Biotechnology startups

Jun Ueki is the CEO at Keiretsu Forum Japan.

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology, Food Processing
  • Stage:Seed
  • Geography: Argentina

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CarLabs
  • Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
Show all investments...

Eduardo Mufarej
Angel · São Paulo, Sao Paulo, Brazil · 1 investments in LATAM Biotechnology startups

Eduardo Mufarej built his career in private equity and education as an investor and entrepreneur. He co-founded and was CEO of Tarpon Investimentos, one of Brazil’s largest independent investment managers. He served on several boards and was Chairman of Somos Educação and Omega Energia Renovável. From 2014 until 2018 Eduardo led the largest k-12company in Latin America, Abril Educação, which he managed until the sale of the company to Kroton Educacional in October 2018. After the sale, Eduardo created Renova, a project focused on selecting and training a new generation of leaders in Brazilian politics. Since its creation, the program has supported and trained over 2000 individuals in Brazil, helping to elect 176 of its students. This effort awarded Eduardo the prize Brazilian Entrepreneur of the Year in 2018. In early 2020, Eduardo co-founded Galena, a company that supports and trains individuals for their first jobs. Eduardo is a member of the advisory board of the Wilson Institute, in Washington, DC, of the Yale University SOM Council of Global Advisors and a fellow at Stanford’s Graduate School of Education.  He is the author of the book Jornada Improvável (Unlikely Journey, 2021).

Show more...

Investment focus

  • Industry: EdTech, Biotechnology, Fuel
  • Stage:Seed, Pre-Seed, Series C
  • Geography: Brazil, Colombia, United States

Investor stats

  • Total investments: 4
  • Round size: Seed $1M–$2M
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • gen-t — Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.
  • HUNTY — HUNTY is a platform that help people find jobs by connecting them with world class mentors who prepare them for the job search process. And people only pay when they get hired.
  • Alicerce — Alicerce is a social impact platform designed to support middle-class education. It offers an educational solution, focused on what is most important and promotes the social ascension of Brazilian families.The company is driven by a mission to provide a successful opportunity for all young Brazilians through quality education.Alicerce wasfounded in 2017 and is headquartered in Sao Paulo, Brazil.
Show all investments...

Mat Travizano
Angel · San Francisco Bay Area, California, United States · 1 investments in LATAM Biotechnology startups

Mat Travizano is the Founder & Chairman at GranData.

Show more...

Investment focus

  • Industry: PaaS, Bitcoin, FinTech
  • Stage:Seed, Series A
  • Geography: Spain, Argentina

Investor stats

  • Total investments: 3
  • Round size: Seed $3.6M–$6.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
  • Reloadly — Send gift cards, airtime & payouts globally with one API. Scalable, instant, developer-friendly platform for rewards and incentives.
  • SenseiNode — We drive the decentralization of the blockchain ecosystem in Latin America with a simple, scalable and secure node management platform.
Show all investments...

Geoffrey KALISH
Angel · New York, New York, United States · 1 investments in LATAM Biotechnology startups

Mr. Kalish is a Partner & Chief Operating Officer at Aquiline Capital Partners.Previously, Mr. Kalish was also the Founder and Managing Director at Venturion Capital. He has served on the boards of numerous financial services companies in Europe and the US. He holds a history degree from Columbia and a masters degree in public policy fromHarvard.

Show more...

Investment focus

  • Industry: AgTech, Seafood, Biotechnology
  • Stage:Series A
  • Geography: Mexico

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Show all investments...

Bob Goodman
Angel · New York, New York, United States · 1 investments in LATAM Biotechnology startups

Robert Goodman is a general partner at Goodman served as a director at he joined Bessemer Venture Partners. He has also worked at Goodman holds a bachelor’s degree in arts from

Show more...

Investment focus

  • Industry: Software, SaaS, Enterprise Software
  • Stage:Series B, Series C, Series A
  • Geography: United States, Mexico, Germany

Investor stats

  • Total investments: 35
  • Round size: Series A $3.9M–$17M; Series B $10M–$40M; Series C $15M–$100M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Fuze, an 8x8 company — Fuze provides a unified, cloud communication software for enterprises that includes call center, phone system and video conferencing solutions.
  • Electric — Electric is a new way to manage your SMBs IT and Security, transforming the way you manage cybersecurity, devices, employees and apps with one place for everything, no tech skills required and all synced with your HR system.
  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Show all investments...

Steve Zurcher
Angel · 1 investments in LATAM Biotechnology startups

Steve Zurcher

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology, Food Processing
  • Stage:Seed
  • Geography: Argentina

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors in LATAM investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 angel investors investing in LATAM Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists